Literature DB >> 18437054

Involvement of PI3K/AKT/GSK3beta pathway in tetrandrine-induced G1 arrest and apoptosis.

Xuan-li Chen1, Kai-huan Ren, Hong-wei He, Rong-guang Shao.   

Abstract

It has been reported that tetrandrine induces cell cycle arrest and apoptosis in human cancer cells. In the present study, we investigated the role of PI3K/AKT/GSK3beta pathway in tetrandrine- induced G(1) arrest and apoptosis. In HT-29 cells, tetrandrine induced dephosphorylation of AKT, activation and nuclear translocation of GSK3beta as well as upregulation of p27(kip1). Activation of GSK3beta via AKT inhibitoion induced by tetrandrine resulted in enhanced phosphorylation and proteolysis of cyclin D(1), activation of caspase 3 and subsequent cleavage of PARP. Selective GSK3beta inhibitiors and GSK3beta siRNA attenuated tetrandrine-induced G(1) arrest and apoptosis. Similar to tetrandrine, transfection of wild-type GSK3beta led to G(1) arrest and apoptosis via downregulation of cyclin D(1) and cleavage of PARP. These findings suggest that tetrandrine induces G(1) arrest and apoptosis through PI3K/AKT/GSK3beta pathway and identify GSK3beta as an important mediator in the processes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18437054     DOI: 10.4161/cbt.7.7.6142

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  23 in total

1.  Tetrandrine inhibits Wnt/β-catenin signaling and suppresses tumor growth of human colorectal cancer.

Authors:  Bai-Cheng He; Jian-Li Gao; Bing-Qiang Zhang; Qing Luo; Qiong Shi; Stephanie H Kim; Enyi Huang; Yanhong Gao; Ke Yang; Eric R Wagner; Linyuan Wang; Ni Tang; Jinyong Luo; Xing Liu; Mi Li; Yang Bi; Jikun Shen; Gaurav Luther; Ning Hu; Qixin Zhou; Hue H Luu; Rex C Haydon; Yingming Zhao; Tong-Chuan He
Journal:  Mol Pharmacol       Date:  2010-10-26       Impact factor: 4.436

2.  c-Jun NH2-terminal kinase-induced proteasomal degradation of c-FLIPL/S and Bcl2 sensitize prostate cancer cells to Fas- and mitochondria-mediated apoptosis by tetrandrine.

Authors:  Pankaj Chaudhary; Jamboor K Vishwanatha
Journal:  Biochem Pharmacol       Date:  2014-08-30       Impact factor: 5.858

3.  Equol inhibits proliferation of human gastric carcinoma cells via modulating Akt pathway.

Authors:  Zhi-Ping Yang; Yan Zhao; Fang Huang; Jie Chen; Ya-Hong Yao; Jun Li; Xiao-Nan Wu
Journal:  World J Gastroenterol       Date:  2015-09-28       Impact factor: 5.742

4.  Tetrandrine Inhibits Epithelial-Mesenchymal Transition in IL-6-Induced HCT116 Human Colorectal Cancer Cells.

Authors:  Shih-Chang Tsai; Wei-Chei Wu; Jai-Sing Yang
Journal:  Onco Targets Ther       Date:  2021-08-21       Impact factor: 4.147

5.  Tetrandrine triggers apoptosis and cell cycle arrest in human renal cell carcinoma cells.

Authors:  Tao Chen; Bing Ji; Yancui Chen
Journal:  J Nat Med       Date:  2013-04-06       Impact factor: 2.343

6.  Extract of Calvatia gigantea inhibits proliferation of A549 human lung cancer cells.

Authors:  Canan Eroğlu; Mücahit Seçme; Pelin Atmaca; Oğuzhan Kaygusuz; Kutret Gezer; Gülseren Bağcı; Yavuz Dodurga
Journal:  Cytotechnology       Date:  2016-01-28       Impact factor: 2.058

7.  Investigation of the Anticancer Mechanism of Isoorientin Isolated from Eremurus Spectabilis Leaves via Cell Cycle Pathways in HT-29 Human Colorectal Adenocarcinoma Cells.

Authors:  Gulsah Gundogdu; Yavuz Dodurga; Levent Elmas; Seymanur Yilmaz Tasci; Esen Sezen Karaoglan
Journal:  Eurasian J Med       Date:  2018-10

8.  Amphetamine Neurotoxicity in PC12 Cells through the PP2A/AKT/GSK3β Pathway.

Authors:  Wenji He; Xinyu Yan; Sanqiang Pan
Journal:  Neurotox Res       Date:  2018-03-06       Impact factor: 3.911

9.  AKT signaling restrains tumor suppressive functions of FOXO transcription factors and GSK3 kinase in multiple myeloma.

Authors:  Timon A Bloedjes; Guus de Wilde; Chiel Maas; Eric Eldering; Richard J Bende; Carel J M van Noesel; Steven T Pals; Marcel Spaargaren; Jeroen E J Guikema
Journal:  Blood Adv       Date:  2020-09-08

10.  Alkaloids isolated from natural herbs as the anticancer agents.

Authors:  Jin-Jian Lu; Jiao-Lin Bao; Xiu-Ping Chen; Min Huang; Yi-Tao Wang
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-04       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.